Dear colleagues,
Ladies and gentlemen,
As president of the annual congress of the German Society of Human Genetics, I am delighted to welcome you to the Garching campus of the Technical University of Munich from March 4 to 6, 2026. Human genetics is entering a phase of accelerated clinical translation: it is shaping diagnostics, therapy decisions, and increasingly also prevention strategies across all medical disciplines.
One focus of the congress is the diagnosis of rare diseases using next-generation sequencing and complementary multi-omics approaches. We will discuss practical pathways from variant detection and functional validation to implementation in healthcare, including quality standards, ethics, data infrastructure, and health economics.
Furthermore, we focus on polygenic risk scores (PRS) for complex diseases. We examine methodology, population transferability, clinical application scenarios, and the role of PRS in preventive medicine, from individualized screening protocols to integrated risk models that include environmental and lifestyle factors.
In Munich, we also represent a dynamically growing focus on neurogenomics. The congress therefore also offers current insights into gene networks of neural development and function, particularly in the field of movement disorders, with a bridge to personalized neuromedicine.
We cordially invite you to contribute with lectures, posters, and discussion contributions—interdisciplinary and critical. Let us show together how human genetic expertise is improving medical practice today and shaping the healthcare of tomorrow.
I look forward to exchanging ideas with you in Munich!
With collegial regards
Prof. Dr. Juliane Winkelmann
Congress President GfH 2026
Technical University of Munich, Garching Campus